Looking to buy the report?


Cluster headache is among the most severe primary headache condition. It is also referred to as the Trigeminal Autonomic Cephalgias. It can affect the individuals of any age group, and is most common among men, occurring among 1 in every 500 people. Some of the important symptoms include prominent autonomic disturbance leading to bloodshot eyes, droopy, puffy, twitch, or tear; the nose will often feel blocked or may run, the ear may feel full or there may be tinnitus, and the skin may get flushed and sweat. Most of them are episodic cases, as compared to the chronic type. It has complex pathophysiology, where the mechanism of pain progression has not been completely understood.

Report Coverage

This report by Mordor Intelligence provides extensive insights of the current scenario and growth prospects of the market studied. Detailed graphical representations of the pipeline landscape, based on various phases and status of clinical trials across major regions of the world are provided, with data obtained from multiple sources. The report also comprises of a list of key sponsors having pipeline products for the concerned market.

Cluster Headache Clinical Trial Analysis, by Phase and Status

  • The clinical trial analysis for cluster headache indicates that there are around XX number of trials under various phases
  • Phase X trials accounted for the majority share
  • The trial data analysis suggests a number of ongoing trials and ones terminated

Cluster Headache Clinical Trials Analysis, by Geography

  • By geography, the scope of the report covers the regional assessment for clinical trials, globally. It covers concise information of registered clinical trials, in different countries, across several developed and emerging markets
  • Some of the major driving factors for the increasing pipeline of cluster headache include misdiagnosis of the disease, as there is no special test for the identification of cluster headache. Rising consumption of alcohol, followed by a large section of the population having difficulties to substances, such as petrol, paint fumes, perfume, bleach, or solvents, triggers the attack. Such factors demand more clinical studies, in order to accurately treat the disease

Key Sponsors in Cluster Headache Clinical Trials

The report will cover analysis on trails and information on key sponsors, companies, and researchers.

Research Methodology

Our data collection team builds scientific research models, based on data sourced from various internal databases, primary and secondary researches, and in-house team of research experts. The pipeline assessment reports are generated, based on the information procured from various stakeholders, such as sponsors, clinical trial organizations, pharmaceutical companies, government bodies, trade agencies, industry journals, scientific literature databases, investor reports, press release statements, and several other sources. The data generated using secondary research and primary research are validated through discussions with industry KOL’s and C-suite executives. The data presented in the reports are continuously updated, to incorporate the most relevant and authentic information to our clients.

Reasons to buy the Report

This report will help you understand

  • The number of clinical trials that are being conducted worldwide
  • The key products under development (Phase I, Phase II, and Phase III)
  • The main area of research under development (by product, mechanism of action, molecule, delivery, etc.)
  • The average recruitment size in trials
  • Key deals between institutions and industries
  • Gather insights on regional and country-level data
  • Review of dormant and discontinued studies across the category
  • Information on key sponsors and profiles
  • Protocol and design comparisons, to generate the best solution for your product development strategy

1. Introduction

2. Research Methodology

3. Disease Epidemiology and Trends

4. Healthcare Expenditure and R&D Trends

5. Executive Summary

6. Clinical Trials Segmentation by Phase

                6.1 Phase-III Product Candidates

                6.2 Phase-II Product Candidates

                6.3 Phase-I Product Candidates

7. Clinical Trials, Segmentation by Status

                7.1 Suspended

                7.2 Terminated

                7.3 Withdrawn

                7.4 Ongoing

                7.5 Completed

                7.6 Others

8. Pipeline Therapeutic Assessment (Infographic Charts and a Brief Description)

                8.1. By Clinical Phase and Molecule Type

                8.2. By Clinical Phase and Route of Administration

                8.3 By Sponsor/Collaborator/Institutions

                8.4 By Geography

9. Market Updates

10. Key Sponsor Profiles

11. Sources and Disclaimer

12. About Mordor Intelligence

Looking to buy the report?

Need a report that reflects how COVID-19 has impacted this market and its growth?

Looking to customize report?



By submitting, you confirm that you agree to our privacy policy